Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 9/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.76 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.76 |
| ▸ | APP | P05067 | 3/20 | 0.76 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.76 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.76 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.76 |
| ▸ | HTR1A | P08908 | 1/20 | 0.76 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.76 |
| ▸ | DRD2 | P14416 | 1/20 | 0.76 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.76 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.76 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.76 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.76 |
| ▸ | HTR2B | P41595 | 1/20 | 0.76 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.76 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.76 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.76 |
| ▸ | CYP2C8 | P10632 | 6/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10762102 | 0.88 | CYP2D6 (0.80) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| SCHEMBL20535918 | 0.87 | CYP2D6 (0.77) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| Amodiaquine SCHEMBL44152 | 0.86 | CYP2D6 (1.00) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| Amodiaquine SCHEMBL29425350 | 0.86 | CYP2D6 (1.00) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| Amodiaquine SCHEMBL29441086 | 0.86 | CYP2D6 (1.00) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| Amodiaquine SCHEMBL29430175 | 0.85 | CYP2D6 (1.00) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| Amodiaquine SCHEMBL317888 | 0.85 | CYP2D6 (1.00) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| Amodiaquine SCHEMBL12094969 | 0.85 | CYP2D6 (1.00) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| Amodiaquine SCHEMBL29788983 | 0.85 | CYP2D6 (1.00) | CYP2D6CYP1A2KCNH2APPNR4A2 | |
| SCHEMBL20536222 | 0.85 | CYP2D6 (0.82) | CYP2D6CYP1A2KCNH2APPNR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170165254-A1 | TREATING FLAVIVIRUS INFECTIONS WITH AMODIAQUINE AND DERIVATIVES THEREOF | GEORGETOWN UNIVERSITY (US) | 2017-06-15 | — | — | US | disclosed |
| US-20170165254-A1 | TREATING FLAVIVIRUS INFECTIONS WITH AMODIAQUINE AND DERIVATIVES THEREOF | GEORGETOWN UNIVERSITY (US) | 2017-06-15 | — | — | US | disclosed |
| WO-2015120127-A2 | TREATING FLAVIVIRUS INFECTIONS WITH AMODIAQUINE AND DERIVATIVES THEREOF | GEORGETOWN UNIVERSITY (US) | 2015-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170165254-A1 | TREATING FLAVIVIRUS INFECTIONS WITH AMODIAQUINE AND DERIVATIVES THEREOF | EIF2AK2, HAVCR2, MAVS | CYP2D6 3889/4885CYP1A2 3717/4885KCNH2 3735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.